A Mark on Alzheimer's disease (AD)
- *Corresponding Author:
- Sai Gireesha P
Yogi Vemana University, Andhra Pradesh, India
Tel: +91 7842371756
E-mail: [email protected]
Received date: 01 March 2015 Accepted date: 28 April 2015
Alzheimer's disease (AD) that accounts for hour to seventieth of cases of dementia. It's a chronic neurodegenerative malady that sometimes starts slowly and gets worse over time. In recent years, noninvasive neuromodulation techniques, such astranscranial magnetic stimulation (TMS) and deep brain stimulation (DBS), emerged as valuable tools within the diagnostic field and will represent candidate treatments for AD, given their therapeutic potential in medical specialty and medical specialty disorders. The identification and validation of biomarkers for diagnosis, watching progression and predicting onset of Alzheimers disesae (AD) are mainly focused.